These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 8877295)

  • 1. Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Diabetologia; 1996 Sep; 39(9):1099-107. PubMed ID: 8877295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Diabetes Care; 2000 May; 23(5):650-7. PubMed ID: 10834425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucose modulation of insulin and glucagon secretion is altered in impaired glucose tolerance.
    Larsson H; Berglund G; Ahrén B
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1778-82. PubMed ID: 7775622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired adaptation of first-phase insulin secretion in postmenopausal women with glucose intolerance.
    Ahrén B; Pacini G
    Am J Physiol; 1997 Oct; 273(4):E701-7. PubMed ID: 9357798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glucose tolerance (IGT) is associated with reduced insulin-induced suppression of glucagon concentrations.
    Ahrén B; Larsson H
    Diabetologia; 2001 Nov; 44(11):1998-2003. PubMed ID: 11719830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta- and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women.
    Ahrén B
    Diabetes; 2009 Mar; 58(3):726-31. PubMed ID: 19095762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women.
    Larsson H; Ahrén B
    Diabetologia; 2000 Feb; 43(2):194-202. PubMed ID: 10753041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterisation of beta-cell dysfunction of impaired glucose tolerance: evidence for impairment of incretin-induced insulin secretion.
    Fritsche A; Stefan N; Hardt E; Häring H; Stumvoll M
    Diabetologia; 2000 Jul; 43(7):852-8. PubMed ID: 10952457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
    Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
    Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
    Faerch K; Vaag A; Holst JJ; Glümer C; Pedersen O; Borch-Johnsen K
    Diabetologia; 2008 May; 51(5):853-61. PubMed ID: 18317726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.
    Weyer C; Bogardus C; Pratley RE
    Diabetes; 1999 Nov; 48(11):2197-203. PubMed ID: 10535454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased insulin-mediated but not non-insulin-dependent glucose disposal rates in glucose intolerance and type II diabetes in African (Ghanaian) immigrants.
    Osei K; Schuster DP
    Am J Med Sci; 1996 Mar; 311(3):113-21. PubMed ID: 8615385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance.
    Larsson H; Ahrén B
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2068-74. PubMed ID: 10372712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Insulin secretion and insulin sensitivity in 1193 inpatients with essential hypertension].
    Tang XF; Li H; Wang JG; Chu SL; Guo JZ; Zhu DL
    Zhonghua Nei Ke Za Zhi; 2004 Oct; 43(10):735-9. PubMed ID: 15631823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Habitual dietary intake versus glucose tolerance, insulin sensitivity and insulin secretion in postmenopausal women.
    Larsson H; Elmståhl S; Berglund G; Ahrén B
    J Intern Med; 1999 Jun; 245(6):581-91. PubMed ID: 10395187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet dysfunction in obese women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Metabolism; 1996 Apr; 45(4):502-9. PubMed ID: 8609839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S; Bédard A; Piché MÈ; Weisnagel SJ; Corneau L; Bergeron J
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.